The affected lot number for both Mirtazapine Tablets 7.5 mg and Mirtazapine Tablets 15 mg are 03119002A3 Exp 03/2022. The FDA is alerting patients and health care professionals to a voluntary recall of 44 lots of losartan potassium tablets by Teva Pharmaceuticals USA and … Find out which specific blood pressure medications are affected by the recall The impurity detected in … For questions about returning the product, contact Qualanex via email at recall@qualanex.com or call 888-280-2046 from 7 a.m. to 4 p.m. CST weekdays.Here are the doses, lot numbers and expiration dates of the recalled medicine: OTTAWA – Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). TYLER, Texas — The FDA announced another recall for certain lots of Losartan tablets. An official website of the United States government: The company said in the statement that for this recall "it has not received any reports of adverse effects. The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing these products. In November, the FDA announced a voluntary recall of losartan potassium/hydrochlorothiazide, 100 mg/25 mg tablets in 1,000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912, Exp. On December 20 th 2018, Torrent Pharmaceuticals Limited announced a voluntary recall of 2 lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The company said in the statement that for this recall "it has not received any reports of … Get regular FDA email updates delivered on this topic to your inbox. The recall was expanded to a total of 10 lots on January 3rd, 2019. Find out which specific blood pressure medications are affected by the recallSearch the full list of recalled angiotensin II receptor blockers (ARB) below by company, medicine, National Drug Code (NDC), lot number, or expiration date The agency says the blood pressure medication contains a potentially cancer causing impurity. Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan. Macleods also recalled one lot of the losartan combination drug in February for the same reason. "Based on the available information, the risk of developing cancer in a few patients following long-term use of the product cannot be ruled out," the recall notice states.The active drug ingredient was manufactured at Hetero Labs Limited in India, one of the overseas drug factories linked to repeated blood medication recalls since last July.Macleods also recalled one lot of the losartan combination drug in February for the same reason. "Health care professionals advise patients to consult with their doctors or pharmacists before discontinuing one of the recalled blood pressure medicines or finding an alternative treatment.Discontinuing a recalled drug could cause more immediate harm than staying on the medication.Consumers with medical questions or to report an adverse event can contact Macleods at 855-926-3384 from 8 a.m. to 5 p.m. EST. The recalled losartan and potassium/hydrochlorothiazide combination tablets contained small amounts of N-nitrosodiethylamine, or NDEA, according to a company notice posted to the Food and Drug Administration's website Wednesday. Torrent is only recalling lots of losartan-containing products that contain N-Methylnitrosobutyric acid (NMBA) above the acceptable daily intake levels released by the FDA. Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen. Drug Safety and Availability